Metabolic and Signaling Dysregulation in a Cellular Model of Hepatic Insulin Resistance
Current Issues in Molecular Biology · 17.07.2026 · 48 (7) · 729
DOI: 10.3390/cimb48070729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 17.07.2026. Verfasst von Hawraa Zbeeb und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Earth, Environment and Life Sciences (DISTAV), University of Genova, Corso Europa 26, 16132 Genova, Italy. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIMA 2022-B4HT_Prima 2022_00124 "Box for Health by Tradition & Innovation: promoting sustainable mediterranean diet by Healthy Foods Progetto, PRIMA Program.
Abstract (Originalsprache)
Insulin resistance (IR) is the underlying pathogenic mechanism for Type 2 Diabetes Mellitus, which is interconnected with Fatty Liver Disease. To investigate the molecular mechanisms by which different metabolic triggers contribute to hepatic IR onset, we exposed human HepG2 hepatocytes to varying glucose concentrations (25–50 mM), and/or insulin (1 nM), and a free fatty acid mixture (0.3 mM), mimicking moderate or severe hyperglycemia, hyperinsulinemia, and steatosis. Glucose consumption, glycogen and lipid droplet (LD) accumulation, gene expression, oxidative stress, and insulin signaling were assessed. Under severe hyperglycemia, both insulin and fatty acids decreased glucose consumption, whereas under moderate hyperglycemia, only insulin had this effect. Glycogen accumulation was increased across all treated conditions. Both insulin and fatty acids triggered steatosis and downregulated PPARγ and SIRT1 mRNA, with insulin increasing LD number, while FFAs increased both LD number and size. All conditions enhanced ROS production, resulting in oxidative stress, but with differences in antioxidant enzyme response. Insulin receptor expression was reduced by insulin and FFAs under moderate hyperglycemia but increased by these stimuli under severe hyperglycemia. Both stimuli enhanced AKT phosphorylation under both hyperglycemic conditions. We conclude that different triggers cooperate in promoting hepatic IR through distinct molecular and signaling mechanisms, suggesting that effective treatments may need to target multiple pathways simultaneously.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Earth, Environment and Life Sciences (DISTAV), University of Genova, Corso Europa 26, 16132 Genova, Italy.
- Nanoscopy and NIC@IIT, Istituto Italiano di Tecnologia (IIT), via Enrico melen 83, 16153 Genova, Italy.
- Department of Physics (DIFI), University of Genova, via Dodecaneso 33, 16146 Genova, Italy.
ORCID-Profile: Hawraa Zbeeb, Alberto Diaspro, Laura Vergani
Förderung
- PRIMA 2022-B4HT_Prima 2022_00124 "Box for Health by Tradition & Innovation: promoting sustainable mediterranean diet by Healthy Foods Progetto
- PRIMA Program
Zitieren
APA
Zbeeb, H., Joumaa, C., De Negri Atanasio, G., Diaspro, A., & Vergani, L. (2026). Metabolic and Signaling Dysregulation in a Cellular Model of Hepatic Insulin Resistance. Current Issues in Molecular Biology, 48(7), 729. https://doi.org/10.3390/cimb48070729
Vancouver
Zbeeb H, Joumaa C, De Negri Atanasio G, Diaspro A, Vergani L. Metabolic and Signaling Dysregulation in a Cellular Model of Hepatic Insulin Resistance. Current Issues in Molecular Biology. 2026;48(7):729. doi:10.3390/cimb48070729
BibTeX
@article{Zbeeb2026,
author = {Zbeeb, Hawraa and Joumaa, Chourouk and De Negri Atanasio, Giulia and Diaspro, Alberto and Vergani, Laura},
title = {Metabolic and Signaling Dysregulation in a Cellular Model of Hepatic Insulin Resistance},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {7},
pages = {729},
doi = {10.3390/cimb48070729}
}
EUVIMED